Yenchieh Cheng

1.2k total citations · 1 hit paper
8 papers, 686 citations indexed

About

Yenchieh Cheng is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yenchieh Cheng has authored 8 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 6 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Yenchieh Cheng's work include Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Yenchieh Cheng is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Yenchieh Cheng collaborates with scholars based in United States, Türkiye and Puerto Rico. Yenchieh Cheng's co-authors include Karen Chu, Robert Vitti, David S. Boyer, Alyson J. Berliner, W. Lloyd Clark, David M. Brown, Jeffrey S. Heier, Kristine Erickson, Yuhwen Soo and Husain Kazmi and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Cornea.

In The Last Decade

Yenchieh Cheng

8 papers receiving 658 citations

Hit Papers

Intravitreal Aflibercept for Macular Edema Following Bran... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yenchieh Cheng United States 7 671 420 89 37 32 8 686
Anna Sala‐Puigdollers Spain 13 554 0.8× 454 1.1× 64 0.7× 24 0.6× 16 0.5× 36 607
Ermete Giancipoli Italy 12 514 0.8× 393 0.9× 63 0.7× 34 0.9× 16 0.5× 35 590
Yi Qu China 11 414 0.6× 273 0.7× 51 0.6× 13 0.4× 22 0.7× 23 449
Claus Zehetner Austria 11 403 0.6× 314 0.7× 83 0.9× 28 0.8× 10 0.3× 44 476
Arghavan Almony United States 15 688 1.0× 597 1.4× 63 0.7× 118 3.2× 15 0.5× 28 729
Franck Fajnkuchen France 15 894 1.3× 747 1.8× 60 0.7× 21 0.6× 11 0.3× 65 933
Ethan Priel Israel 14 492 0.7× 284 0.7× 49 0.6× 17 0.5× 21 0.7× 21 519
Kuniharu Saito Japan 6 612 0.9× 417 1.0× 54 0.6× 22 0.6× 15 0.5× 7 625
Mali Okada Australia 13 666 1.0× 522 1.2× 86 1.0× 20 0.5× 7 0.2× 30 726
Ahmed Souka Egypt 12 351 0.5× 238 0.6× 48 0.5× 9 0.2× 16 0.5× 24 383

Countries citing papers authored by Yenchieh Cheng

Since Specialization
Citations

This map shows the geographic impact of Yenchieh Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yenchieh Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yenchieh Cheng more than expected).

Fields of papers citing papers by Yenchieh Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yenchieh Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yenchieh Cheng. The network helps show where Yenchieh Cheng may publish in the future.

Co-authorship network of co-authors of Yenchieh Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yenchieh Cheng. A scholar is included among the top collaborators of Yenchieh Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yenchieh Cheng. Yenchieh Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wykoff, Charles C., V. Diana, W. Lloyd Clark, et al.. (2024). Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA. Ophthalmology Retina. 9(1). 91–94. 1 indexed citations
2.
Heier, Jeffrey S., Allen C. Ho, David S. Boyer, et al.. (2022). Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial. Journal of VitreoRetinal Diseases. 7(1). 8–15. 9 indexed citations
3.
Brown, David M., Charles C. Wykoff, David S. Boyer, et al.. (2021). Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy. JAMA Ophthalmology. 139(9). 946–946. 92 indexed citations
4.
Khurana, Rahul N., Ehsan Rahimy, Namrata Saroj, et al.. (2019). Extended (Every 12 Weeks or Longer) Dosing Interval With Intravitreal Aflibercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of VIEW Trials. American Journal of Ophthalmology. 200. 161–168. 26 indexed citations
5.
Heissigerová, Jarmila, David Callanan, Marc D. de Smet, et al.. (2018). Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):. Ophthalmology. 126(3). 428–437. 49 indexed citations
6.
Lass, Jonathan H., Beth Ann Benetz, Harry Menegay, et al.. (2018). Effects of Repeated Intravitreal Aflibercept Injection on the Corneal Endothelium in Patients With Age-Related Macular Degeneration: Outcomes From the RE-VIEW Study. Cornea. 37(5). 596–601. 9 indexed citations
7.
Clark, W. Lloyd, David S. Boyer, Jeffrey S. Heier, et al.. (2015). Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion. Ophthalmology. 123(2). 330–336. 190 indexed citations
8.
Campochiaro, Peter A., W. Lloyd Clark, David S. Boyer, et al.. (2014). Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion. Ophthalmology. 122(3). 538–544. 310 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026